Giant-cell tumor of bone : treatment options and role of denosumab

Discusses the role of denosumab, a monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), in modifying the pathogenesis of giant-cell tumor of bone (GCTB), and the evolving management of GCTB with the introduction of denosumab. Source: National Library of New Zealand Te...

Full description

Saved in:
Bibliographic Details
Published in:Biologics 2015-01, Vol.9 (default), p.69-74
Main Authors: Singh, Arun S, Chawla, Neal S, Chawla, Sant P
Format: Article
Language:English
Subjects:
Analysis
Bone cancer
Bones
Cancer therapies
Care and treatment
Complications and side effects
Drug approval
Giant cell tumors
Immunotherapy
Influence
Metastasis
Monoclonal antibodies
Mutation
Pathogenesis
Radiation therapy
Review
Sarcoma
Targeted cancer therapy
Therapeutic use
Treatment
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c666t-b52f6b1774d162b76b1a77f53d9702d1879049a2a3a4f3d640204fbb1deff39d3
cites
container_end_page 74
container_issue default
container_start_page 69
container_title Biologics
container_volume 9
creator Singh, Arun S
Chawla, Neal S
Chawla, Sant P
description Discusses the role of denosumab, a monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), in modifying the pathogenesis of giant-cell tumor of bone (GCTB), and the evolving management of GCTB with the introduction of denosumab. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
doi_str_mv 10.2147/btt.s57359
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_63d3a940dabe42b59981387a6eea2a4f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A445606462</galeid><doaj_id>oai_doaj_org_article_63d3a940dabe42b59981387a6eea2a4f</doaj_id><sourcerecordid>A445606462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c666t-b52f6b1774d162b76b1a77f53d9702d1879049a2a3a4f3d640204fbb1deff39d3</originalsourceid><addsrcrecordid>eNqFkk2LFDEQhhtR3HX04g-QBi8i9JivTjoeFnYXXRcWPDieQ9JJxh66kzFJi_rrrdlZZx0RJIcqkidvqt5UVT3HaEkwE29MKcvcCtrKB9UpxkI0LZP44SEX7Un1JOcNQpygjj-uTggklBB8Wl1cDTqUpnfjWJd5iqmOvjYxuPptXZLTZXKh1HFbhhhyrYOtUxzdDrIuxDxP2jytHnk9ZvfsLi6qz-_frS4_NDcfr64vz2-annNeGtMSzw1UxCzmxAjItRC-pVYKRCzuhERMaqKpZp5azhBBzBuDrfOeSksX1fVe10a9Uds0TDr9UFEP6nYjprXSqQz96BSnlmrJkNXGMWJaKTtMO6G5c_AAyC-qs73WdjaTsz00mfR4JHp8EoYvah2_KdYiwVoOAq_uBFL8Ortc1DTknYs6uDhnhTsiJOEYfP4vymUnOXiwQ1_-hW7inAK4qgghtJOUYnZPrTX0OgQfocR-J6rOGRSHOOMEqOU_KFjWTUMPP-wH2D-68Hp_oU8x5-T8wQ6M1G7Q1MVqpT7dDhrAL_408ID-nqz7IsMYfsLz1n2HCB_BqMSYckQ6Kugv_wrVdg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2223893314</pqid></control><display><type>article</type><title>Giant-cell tumor of bone : treatment options and role of denosumab</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Taylor &amp; Francis Open Access Journals</source><creator>Singh, Arun S ; Chawla, Neal S ; Chawla, Sant P</creator><creatorcontrib>Singh, Arun S ; Chawla, Neal S ; Chawla, Sant P</creatorcontrib><description>Discusses the role of denosumab, a monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), in modifying the pathogenesis of giant-cell tumor of bone (GCTB), and the evolving management of GCTB with the introduction of denosumab. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><identifier>ISSN: 1177-5475</identifier><identifier>ISSN: 1177-5491</identifier><identifier>EISSN: 1177-5491</identifier><identifier>DOI: 10.2147/btt.s57359</identifier><identifier>PMID: 26203221</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Analysis ; Bone cancer ; Bones ; Cancer therapies ; Care and treatment ; Complications and side effects ; Drug approval ; Giant cell tumors ; Immunotherapy ; Influence ; Metastasis ; Monoclonal antibodies ; Mutation ; Pathogenesis ; Radiation therapy ; Review ; Sarcoma ; Targeted cancer therapy ; Therapeutic use ; Treatment ; Tumors</subject><ispartof>Biologics, 2015-01, Vol.9 (default), p.69-74</ispartof><rights>COPYRIGHT 2015 Dove Medical Press Limited</rights><rights>2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Singh et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c666t-b52f6b1774d162b76b1a77f53d9702d1879049a2a3a4f3d640204fbb1deff39d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2223893314/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2223893314?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,998439113602837&amp;tab=innz&amp;search_scope=INNZ&amp;vid=NLNZ&amp;offset=0$$DView this record in NLNZ$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26203221$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Arun S</creatorcontrib><creatorcontrib>Chawla, Neal S</creatorcontrib><creatorcontrib>Chawla, Sant P</creatorcontrib><title>Giant-cell tumor of bone : treatment options and role of denosumab</title><title>Biologics</title><addtitle>Biologics</addtitle><description>Discusses the role of denosumab, a monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), in modifying the pathogenesis of giant-cell tumor of bone (GCTB), and the evolving management of GCTB with the introduction of denosumab. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><subject>Analysis</subject><subject>Bone cancer</subject><subject>Bones</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Drug approval</subject><subject>Giant cell tumors</subject><subject>Immunotherapy</subject><subject>Influence</subject><subject>Metastasis</subject><subject>Monoclonal antibodies</subject><subject>Mutation</subject><subject>Pathogenesis</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Sarcoma</subject><subject>Targeted cancer therapy</subject><subject>Therapeutic use</subject><subject>Treatment</subject><subject>Tumors</subject><issn>1177-5475</issn><issn>1177-5491</issn><issn>1177-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkk2LFDEQhhtR3HX04g-QBi8i9JivTjoeFnYXXRcWPDieQ9JJxh66kzFJi_rrrdlZZx0RJIcqkidvqt5UVT3HaEkwE29MKcvcCtrKB9UpxkI0LZP44SEX7Un1JOcNQpygjj-uTggklBB8Wl1cDTqUpnfjWJd5iqmOvjYxuPptXZLTZXKh1HFbhhhyrYOtUxzdDrIuxDxP2jytHnk9ZvfsLi6qz-_frS4_NDcfr64vz2-annNeGtMSzw1UxCzmxAjItRC-pVYKRCzuhERMaqKpZp5azhBBzBuDrfOeSksX1fVe10a9Uds0TDr9UFEP6nYjprXSqQz96BSnlmrJkNXGMWJaKTtMO6G5c_AAyC-qs73WdjaTsz00mfR4JHp8EoYvah2_KdYiwVoOAq_uBFL8Ortc1DTknYs6uDhnhTsiJOEYfP4vymUnOXiwQ1_-hW7inAK4qgghtJOUYnZPrTX0OgQfocR-J6rOGRSHOOMEqOU_KFjWTUMPP-wH2D-68Hp_oU8x5-T8wQ6M1G7Q1MVqpT7dDhrAL_408ID-nqz7IsMYfsLz1n2HCB_BqMSYckQ6Kugv_wrVdg</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Singh, Arun S</creator><creator>Chawla, Neal S</creator><creator>Chawla, Sant P</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>GOM</scope><scope>LETOP</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QP</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150101</creationdate><title>Giant-cell tumor of bone : treatment options and role of denosumab</title><author>Singh, Arun S ; Chawla, Neal S ; Chawla, Sant P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c666t-b52f6b1774d162b76b1a77f53d9702d1879049a2a3a4f3d640204fbb1deff39d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Analysis</topic><topic>Bone cancer</topic><topic>Bones</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Drug approval</topic><topic>Giant cell tumors</topic><topic>Immunotherapy</topic><topic>Influence</topic><topic>Metastasis</topic><topic>Monoclonal antibodies</topic><topic>Mutation</topic><topic>Pathogenesis</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Sarcoma</topic><topic>Targeted cancer therapy</topic><topic>Therapeutic use</topic><topic>Treatment</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Arun S</creatorcontrib><creatorcontrib>Chawla, Neal S</creatorcontrib><creatorcontrib>Chawla, Sant P</creatorcontrib><collection>Index New Zealand</collection><collection>Index New Zealand (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep (ProQuest)</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Research Library</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Biologics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Arun S</au><au>Chawla, Neal S</au><au>Chawla, Sant P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Giant-cell tumor of bone : treatment options and role of denosumab</atitle><jtitle>Biologics</jtitle><addtitle>Biologics</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>9</volume><issue>default</issue><spage>69</spage><epage>74</epage><pages>69-74</pages><issn>1177-5475</issn><issn>1177-5491</issn><eissn>1177-5491</eissn><abstract>Discusses the role of denosumab, a monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), in modifying the pathogenesis of giant-cell tumor of bone (GCTB), and the evolving management of GCTB with the introduction of denosumab. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>26203221</pmid><doi>10.2147/btt.s57359</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-5475
ispartof Biologics, 2015-01, Vol.9 (default), p.69-74
issn 1177-5475
1177-5491
1177-5491
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_63d3a940dabe42b59981387a6eea2a4f
source Open Access: PubMed Central; Publicly Available Content Database; Taylor & Francis Open Access Journals
subjects Analysis
Bone cancer
Bones
Cancer therapies
Care and treatment
Complications and side effects
Drug approval
Giant cell tumors
Immunotherapy
Influence
Metastasis
Monoclonal antibodies
Mutation
Pathogenesis
Radiation therapy
Review
Sarcoma
Targeted cancer therapy
Therapeutic use
Treatment
Tumors
title Giant-cell tumor of bone : treatment options and role of denosumab
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Giant-cell%20tumor%20of%20bone%20:%20treatment%20options%20and%20role%20of%20denosumab&rft.jtitle=Biologics&rft.au=Singh,%20Arun%20S&rft.date=2015-01-01&rft.volume=9&rft.issue=default&rft.spage=69&rft.epage=74&rft.pages=69-74&rft.issn=1177-5475&rft.eissn=1177-5491&rft_id=info:doi/10.2147/btt.s57359&rft_dat=%3Cgale_doaj_%3EA445606462%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c666t-b52f6b1774d162b76b1a77f53d9702d1879049a2a3a4f3d640204fbb1deff39d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2223893314&rft_id=info:pmid/26203221&rft_galeid=A445606462&rfr_iscdi=true